Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 08/28/2020

Summary

A Form 4 filed with the Securities and Exchange Commission for Kelly Scott A., as the name is printed, a director and officer of CytoDyn Inc. (CYDY) with the title "Chairman & CMO". It reports a gift on 08/28/2020 of 74,800 shares of common stock by the reporting person's spouse to the spouse's daughter, who shares the reporting person's household: the spouse's indirect line falls to 616,408 shares and the line for shares owned by a custodian for the daughter rises to 97,980. The explanation says the reporting person disclaims beneficial ownership of the shares of the reporting person's spouse and daughter, and that the report is not an admission that the reporting person is their beneficial owner for Section 16 or any other purpose. Arian Colachis signed as attorney-in-fact on 09/01/2020.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Kelly Scott A. (Last) (First) (Middle) C/O CYTODYN INC. 1111 MAIN STREET, SUITE 660 (Street) VANCOUVER WA 98660 (City) (State) (Zip) | Kelly Scott A. | (Last) | (First) | (Middle) | C/O CYTODYN INC. | 1111 MAIN STREET, SUITE 660 | VANCOUVER | WA | 98660 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol CytoDyn Inc. [ CYDY ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Chairman & CMO | X | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | Chairman & CMO
3. Date of Earliest Transaction
 (Month/Day/Year) 08/28/2020
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 08/28/2020 | G | 74,800 (1) | D | $ 0 | 616,408 | I | By Spouse
Common Stock | 08/28/2020 | G | 74,800 (1) | A | $ 0 | 97,980 | I | By Custodian for daughter
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Explanation of Responses:
1. This transaction involved a gift of securities by the spouse of the reporting person to her daughter, who shares reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his spouse and his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of either his spouse's shares or his daughter's shares for purposes of Section 16 or for any other purpose.
Arian Colachis, attorney-in-fact | 09/01/2020
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_CYDY_4_filed2020-09-01_0001807094-20-000016.xml

Size

16,025 bytes

SHA-256

b9d92384cb54fbf7c3643ac8a45d16383cbbd3dc1686ccb0d2ff8766796f5d6e

Our copy

SEC_CYDY_4_filed2020-09-01_0001807094-20-000016.xml

Original

www.sec.gov